search
Back to results

Effect of Saliva Substitutes on Dental Hard Tissues in Situ (T-01)

Primary Purpose

Hyposalivation

Status
Terminated
Phase
Phase 2
Locations
Germany
Study Type
Interventional
Intervention
Glandosane
Saliva natura
Sponsored by
Charite University, Berlin, Germany
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hyposalivation focused on measuring enamel, dentin, saliva substitute, demineralization, remineralization

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • stimulated salivary flow rate < 0.5 ml/min
  • partial denture upper or lower jaw
  • radiationtherapy in the head and neck area
  • patient age above 18 years
  • Signed informed consent (AMG §40 (1) 3b)

Exclusion Criteria:

  • stimulated salivary flow rate > 0.5 ml/min
  • missing partial denture upper or lower jaw
  • missing Radiationtherapy in the head and neck area
  • paraben allergy
  • not signed informed consent (AMG §40 (1) 3b)

Sites / Locations

  • Charite, Berlin, Germany
  • Charité - Universitätsmedizin Berlin

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Glandosane

Saliva natura

Arm Description

After in situ exposition the enamel and dentin samples will demineralize with Glandosane.

After in situ exposition the enamel and dentin samples will remineralize with Saliva natura

Outcomes

Primary Outcome Measures

Mineral loss and lesion depth of specimens
Evaluation of the mineral loss/lesion depth of the enamel and dentin specimens after in situ exposition evaluated with transversal microradiography. The Unit is the mineral oss as well as lesion depth.

Secondary Outcome Measures

general and oral well being
Evaluation of the general and oral well being before and after therapy by questionnaires.

Full Information

First Posted
June 30, 2010
Last Updated
November 12, 2011
Sponsor
Charite University, Berlin, Germany
search

1. Study Identification

Unique Protocol Identification Number
NCT01165970
Brief Title
Effect of Saliva Substitutes on Dental Hard Tissues in Situ
Acronym
T-01
Official Title
Vergleichende, Randomisierte, Kontrollierte Und Doppelblinde In-situ-Studie Zur Wirkung Von Speichelersatzmitteln Auf Schmelz Und Dentin
Study Type
Interventional

2. Study Status

Record Verification Date
November 2011
Overall Recruitment Status
Terminated
Study Start Date
January 2009 (undefined)
Primary Completion Date
March 2012 (Anticipated)
Study Completion Date
December 2012 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Charite University, Berlin, Germany

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Symptomatic hyposalivation is associated not only with Sjögren's syndrome or salivary gland hypofunction in elderly patients, but also with medications containing antimuscarinic drugs, chemo radiotherapy for head and neck carcinomas, and psychiatric disorders (Atkinson & Ava, 1994, Kielbassa et al., 2006). Human saliva possesses important physiological functions in protecting and moistening the oral hard and soft tissues (Piotrowski et al., 1992, ). Consequently, decreasing salivation causes oral dysfunction and promotes severe oral side effects (reduced antibacterial function, lack of remineralisation, reduced buffer capacity) (Tschoppe et al., 2010a). These have been identified as being responsible for the rapid destruction of the dentition (Willich et al., 1988). Saliva substitutes are frequently applied for relieving the symptoms in patients suffering from hyposalivation (Hahnel et al., 2009, Nieuw Amerongen & Veerman, 2003, Vissink et al., 2004). Besides the moistening and lubrication of the oral mucosa, these products should also protect dental hard tissues. However, in vitro studies revealed that some marketed products have only a neutral or even a demineralising potential on enamel as well as on dentin (Kielbassa et al., 2001, Meyer-Lueckel et al., 2002, Smith et al., 2001, Tschoppe et al., 2009). Inorganic ions such as calcium, phosphates, and fluorides have been added to saliva substitutes in order to enhance their remineralising property or minimize their demineralising potential (Tschoppe et al., 2009). Furthermore, as most patients suffering from hyposalivation are elderly people, recessions and subsequently exposed dentin surfaces are very common. Since dentin is not as acid resistant as enamel, an earlier and more severe demineralisation can be expected (Saunders & Meyerowitz, 2005). Therefore, the current in situ study was performed to assess the effects of a demineralising and a remineralising saliva substitutes on the mineralisation of dental hard tissues. It was hypothesized that storage in Glandosane(cell pharm, Hannover, Germany) would not result in pronounced mineral loss of dentin specimens, and that storage in Saliva natura would not result in enhanced remineralisation when combined with a remineralising artificial saliva (Saliva natura supersaturated with respect to relevant calcium phosphates; medac, Hamburg, Germany) (H0). These null hypotheses were tested against the alternative hypothesis of a difference.
Detailed Description
see application for the German Federal Institute for Drugs and Medical Devices at Eudra-CT

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyposalivation
Keywords
enamel, dentin, saliva substitute, demineralization, remineralization

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
19 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Glandosane
Arm Type
Active Comparator
Arm Description
After in situ exposition the enamel and dentin samples will demineralize with Glandosane.
Arm Title
Saliva natura
Arm Type
Experimental
Arm Description
After in situ exposition the enamel and dentin samples will remineralize with Saliva natura
Intervention Type
Drug
Intervention Name(s)
Glandosane
Other Intervention Name(s)
Glandosane, Cell Pharm, Germany
Intervention Description
according to the german law the sued saliva substitute is a drug (Glandosane) whereas Saliva natura is a medical product
Intervention Type
Device
Intervention Name(s)
Saliva natura
Other Intervention Name(s)
Saliva natura, Medac, Germany
Intervention Description
Saliva substitute without restriction to be used
Primary Outcome Measure Information:
Title
Mineral loss and lesion depth of specimens
Description
Evaluation of the mineral loss/lesion depth of the enamel and dentin specimens after in situ exposition evaluated with transversal microradiography. The Unit is the mineral oss as well as lesion depth.
Time Frame
15 weeks
Secondary Outcome Measure Information:
Title
general and oral well being
Description
Evaluation of the general and oral well being before and after therapy by questionnaires.
Time Frame
15 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: stimulated salivary flow rate < 0.5 ml/min partial denture upper or lower jaw radiationtherapy in the head and neck area patient age above 18 years Signed informed consent (AMG §40 (1) 3b) Exclusion Criteria: stimulated salivary flow rate > 0.5 ml/min missing partial denture upper or lower jaw missing Radiationtherapy in the head and neck area paraben allergy not signed informed consent (AMG §40 (1) 3b)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter Tschoppe, Dr
Organizational Affiliation
Department of Operative Dentistry and Periodontology, School of Dental Medicine, CharitéCentrum 3, Charité - Universitätsmedizin Berlin
Official's Role
Principal Investigator
Facility Information:
Facility Name
Charite, Berlin, Germany
City
Berlin
ZIP/Postal Code
14197
Country
Germany
Facility Name
Charité - Universitätsmedizin Berlin
City
Berlin
ZIP/Postal Code
14197
Country
Germany

12. IPD Sharing Statement

Citations:
PubMed Identifier
21477333
Citation
Tschoppe P, Wolf O, Eichhorn M, Martus P, Kielbassa AM. Design of a randomized controlled double-blind crossover clinical trial to assess the effects of saliva substitutes on bovine enamel and dentin in situ. BMC Oral Health. 2011 Apr 9;11:13. doi: 10.1186/1472-6831-11-13.
Results Reference
derived
Links:
URL
http://kons-paro.charite.de
Description
please check the science subsite
URL
http://www.ncbi.nlm.nih.gov/pubmed/20305867
Description
Short review on the main problems in this patient population: Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int. 2010 Apr;41(4):321-33. Review.

Learn more about this trial

Effect of Saliva Substitutes on Dental Hard Tissues in Situ

We'll reach out to this number within 24 hrs